Celldex Therapeutics Inc. Logo Image

Celldex Therapeutics Inc.

Celldex Therapeutics Inc. Banner Image

Celldex Therapeutics Inc. has reached its limit for profile views.

Please check back to see if Celldex Therapeutics Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2015 Annual Report and Form 10K

Celldex Therapeutics Inc.

Celldex Therapeutics Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Celldex Therapeutics Inc.

51-200 Employees
Based in Hampton, New Jersey

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates.

Ticker:
CLDX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Diagnostic Substances (See More Diagnostic Substances Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol